Global Machine Translation Market to Witness High Growth During 2017 – 2023     |    Global Workplace Transformation Market to Witness 17.4% CAGR during 2017 – 2023     |    Global Data Science Platform Market to Witness 39.3% CAGR During 2017 – 2023

Toll Free (US/Canada): 1-888-778-7886

INT'L: 1-347-960-6455

enquiry@psmarketresearch.com

P&S Market Research - A market research firm

Animal Pharmaceuticals Market

P&S Market Research-Animal Pharmaceuticals Market report

Global Animal Pharmaceuticals Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators, and Others), by Animal Type (Companion Animals and Production Animals)

Published: October 2016
Report Code: CP10742
Available Format: pdf
Pages: 146

Animal pharmaceutical refers to drugs to diagnose, cure and treat veterinary disease and disorders of a particular type. The production animals are nurtured by consumers for milk and meat related products; whereas, the companion animals are adopted for office or house guards and companionship. Animals have been a major part of human life, and awareness for their health and wellbeing has never been more important. Increasing demand for higher efficiency of livestock production and growing human and animal bond and pet ownership is supporting the growth of animal pharmaceuticals market.

The global animal pharmaceuticals market was valued at $12,614.3 million in 2015, and it is expected to grow at a CAGR of 7.7% during 2016 - 2022. The increasing consumption of meat and milk, increasing zoonotic and food borne diseases, and increasing trend of pet adoption are the key factors driving the growth of the global market.

The evolution of new diseases in animals and emerging economies offer ample opportunities for the growth of animal pharmaceuticals market. To find enhanced solutions for prevailing and new diseases, the companies in the animal pharmaceuticals market are active in research and development activities. Evolution of new diseases in animals drives the research and development of new pharmaceuticals for the treatment of these diseases. Different companies are targeting research for the development of new drugs and to exploit market potential. However, increasing cost and regulation in animal testing and restrictions imposed by regulatory authorities affecting antibiotic sales are expected to hamper the growth of the global market to some extent.

Animal owners are being encouraged by government to take appropriate protective measures for their animals. The animal pharmaceutical products include ectoparasiticides, endoparasiticides, anti-inflammatories, bronchodilators, and others. Among the different types of animal pharmaceutical products, the ectoparasiticides generated largest revenue in the global animal pharmaceuticals market in 2015. Among the two types of animals, the largest revenue was generated from the sales of animal pharmaceuticals for companion animals in 2015. The animal pharmaceuticals market for production animals would witness faster growth during the forecast period, owing to the increasing awareness about the livestock related diseases.

North America accounted for the largest share in the global market in 2015 and it is expected to grow at the considerable rate during the forecast period. The factors driving the animal pharmaceuticals market in the region are high level of urbanization, high standard of living, and high consumption of meat and milk products. Europe was the second largest market for animal pharmaceuticals devices in 2015. The European market is primarily driven by increasing awareness about the diseases associated with livestock and companion animals.

The animal pharmaceuticals market in Asia-Pacific would witness highest growth during the forecast period. The highest growth in the region is attributed to the surging export of animal products in the region, which is impelling the animal farm owners to keep their animals in good health, as animal products for export have to pass through several scrutiny processes. The improving standard of living of people in countries such as China, India and Indonesia is also escalating the number of companion animals.

Some of the major players operating in the global market include Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc., Virbac SA, Boehringer Ingelheim GmbH , Perrigo Company plc,  Eli Lilly and Company, Sanofi and Bayer AG.

Chapter 1. Research Scope and Methodology

1.1 Objectives of the Study

1.2 Market Definition

1.3 Research Scope

1.3.1 Global animal pharmaceuticals market breakdown by product

1.3.2 Global animal pharmaceuticals market breakdown by animal type

1.3.3 Global animal pharmaceuticals market breakdown by region

1.4 Analysis Period

1.5 Calculation Methodology

1.6 Research Methodology and Sources

1.7 Stakeholders in the Animal Pharmaceuticals Market

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

2.3 Market Snapshot

Chapter 3. Market Outlook

3.1 Introduction

3.2 Trends in the Global Animal Pharmaceuticals Market

3.2.1 Declining research and development productivity

3.2.2 Growth of generic and over-the-counter (OTC) drugs for animal care

3.3 Opportunities in the Global Animal Pharmaceuticals Market

3.3.1 Evolution of new diseases in animals

3.3.2 Emerging economies offering growth opportunities

3.4 Factors Driving the Growth of Market and its Impact on Market Forecast

3.4.1 Increasing global consumption of meat and milk

3.4.2 Increasing trend of pet adoption

3.4.3 Increasing zoonotic and food borne diseases

3.4.4 Impact analysis of drivers on market forecast

3.5 Factors Hindering Growth of the Market and its Impact on Market Forecast

3.5.1 Increasing cost and regulations in animal testing

3.5.2 Restrictions imposed by regulatory authorities affecting antibiotic sales in the animal pharmaceuticals market

3.5.3 Impact analysis of restraints on market forecast

Chapter 4. Animal Pharmaceuticals Market Size & Forecast (2012 – 2022)

4.1 Animal Pharmaceuticals Market Breakdown by Product

4.1.1 Ectoparasiticides

4.1.2 Endoparasiticides

4.1.3 Anti-Inflammatories

4.1.4 Bronchodilators

4.1.5 Others

4.2 Animal Pharmaceuticals Market Breakdown by Animal Type

4.2.1 Companion animals

4.2.2 Production animals

4.3 Animal Pharmaceuticals Market Breakdown by Region

Chapter 5. Animal Pharmaceuticals Market, by Product

5.1 Global Ectoparasiticides Market, by Type

5.1.1 Ivermectin

5.1.2 Cypermethrin

5.1.3 Fipronil

5.1.4 Coumaphos

5.1.5 Others

5.2 Global Endoparasiticides Market, by Type

5.2.1 Ivermectin

5.2.2 Praziquantel

5.2.3 Flubendazole

5.2.4 Milbemycin

5.2.5 Levamisole

5.2.6 Fenbendazole

5.2.7 Pyrantel

5.2.8 Others

5.3 Global Anti-Inflammatories Market, by Type

5.3.1 NSAIDs

5.3.2 Corticosteroids

5.3.3 Others

5.4 Global Animal Bronchodilators Market, by Type

5.4.1 Theophylline

5.4.2 Albuterol

5.4.3 Others

Chapter 6. Animal Pharmaceuticals Market, by Animal Type

6.1 Global Companion Animal Pharmaceuticals Market, by Product

6.1.1 Global canine pharmaceuticals market, by product

6.1.1.1 Global canine ectoparasiticides market, by type

6.1.1.2 Global canine endoparasiticides market, by type

6.1.1.3 Global canine anti-inflammatories market, by type

6.1.1.4 Global canine bronchodilators market by type

6.1.2 Global feline pharmaceuticals market, by product

6.1.2.1 Global feline ectoparasiticides market, by type

6.1.2.2 Global feline endoparasiticides market, by type

6.1.2.3 Global feline anti-inflammatories market, by type

6.1.2.4 Global feline bronchodilators market, by type

6.1.3 Global equine pharmaceuticals market, by product

6.1.3.1 Global equine ectoparasiticides market, by type

6.1.3.2 Global equine endoparasiticides market, by type

6.1.3.3 Global equine anti-inflammatories market, by type

6.1.3.4 Global equine bronchodilators market, by type

6.2 Global Production Animals Pharmaceuticals Market, by Product

6.2.1 Global livestock pharmaceuticals market, by product

6.2.1.1 Global livestock ectoparasiticides market, by type

6.2.1.2 Global livestock endoparasiticides market, by type

6.2.1.3 Global livestock anti-inflammatories market, by type

6.2.2 Global poultry pharmaceuticals market, by product

6.2.2.1 Global poultry ectoparasiticides market, by type

6.2.2.2 Global poultry endoparasiticides market, by type

Chapter 7. Global Animal Pharmaceuticals Market, by Geography

7.1 North America Animal Pharmaceuticals Market

7.1.1 North America animal pharmaceuticals market, by product

7.1.1.1 North America ectoparasiticides market, by type

7.1.1.2 North America endoparasiticides market, by type

7.1.1.3 North America anti-inflammatories market, by type

7.1.1.4 North America bronchodilators market, by type

7.1.2 North America animal pharmaceuticals market, by animal type

7.1.2.1 North America companion animal pharmaceuticals market, by specie

7.1.2.2 North America production animal pharmaceuticals market, by specie

7.1.3 North America animal pharmaceuticals market, by country

7.1.3.1 U.S. animal pharmaceuticals market, by product

7.2 Europe Animal Pharmaceuticals Market

7.2.1 Europe animal pharmaceuticals market, by product

7.2.1.1 Europe ectoparasiticides market, by type

7.2.1.2 Europe endoparasiticides market, by type

7.2.1.3 Europe anti-inflammatories market, by type

7.2.1.4 Europe bronchodilators market, by type

7.2.2 Europe animal pharmaceuticals market, by animal type

7.2.2.1 Europe companion animal pharmaceuticals market, by specie

7.2.2.2 Europe production animal pharmaceuticals market, by specie

7.2.3 Europe animal pharmaceuticals market, by country

7.2.3.1 Germany animal pharmaceuticals market, by product

7.2.3.2 France animal pharmaceuticals market, by product

7.2.3.3 U.K. animal pharmaceuticals market, by product

7.2.3.4 Italy animal pharmaceuticals market, by product

7.3 Asia-Pacific Animal Pharmaceuticals Market

7.3.1 Asia-Pacific animal pharmaceuticals market, by product

7.3.1.1 Asia-Pacific ectoparasiticides market, by type

7.3.1.2 Asia-Pacific endoparasiticides market, by type

7.3.1.3 Asia-Pacific anti-inflammatories market, by type

7.3.1.4 Asia-Pacific bronchodilators market, by type

7.3.2 Asia-Pacific animal pharmaceuticals market, by animal type

7.3.2.1 Asia-Pacific companion animal pharmaceuticals market, by specie

7.3.2.2 Asia-Pacific production animal pharmaceuticals market by, specie

7.3.3 Asia-Pacific animal pharmaceuticals market, by country

7.3.3.1 China animal pharmaceuticals market, by product

7.3.3.2 India animal pharmaceuticals market, by product

7.3.3.3 Australia animal pharmaceuticals market, by product

7.4 Rest of the World (RoW) Animal Pharmaceuticals Market

7.4.1 RoW animal pharmaceuticals market, by product

7.4.1.1 RoW ectoparasiticides market, by type

7.4.1.2 RoW endoparasiticides market, by type

7.4.1.3 RoW anti-inflammatories market, by type

7.4.1.4 RoW bronchodilators market, by type

7.4.2 RoW animal pharmaceuticals market, by animal type

7.4.2.1 RoW companion animal pharmaceuticals market by specie

7.4.2.2 RoW production animal pharmaceuticals market, by specie

7.4.3 RoW animal pharmaceuticals market, by country

7.4.3.1 Brazil animal pharmaceuticals market by product

Chapter 8. Competitive Positioning Analysis

8.1 Porter's Five Forces of Competitive Position Analysis

8.1.1 Bargaining power of buyers

8.1.2 Bargaining power of suppliers

8.1.3 Threat of new entrants

8.1.4 Intensity of rivalry

8.1.5 Threat of substitutes

8.2 Competitive Positioning of Global Animal Pharmaceuticals Market

Chapter 9. Company Profiles and Strategic Developments

9.1 Key Company Profiles

9.1.1 Merck & Co., Inc.

9.1.1.1 Business overview

9.1.1.2 Product and service offerings

9.1.2 Vetoquinol S.A.

9.1.2.1 Business overview

9.1.2.2 Product and service offerings

9.1.3 Zoetis Inc.

9.1.3.1 Business overview

9.1.3.2 Product and service offerings

9.1.4 Virbac SA

9.1.4.1 Business overview

9.1.4.2 Product and service offerings

9.1.5 Boehringer Ingelheim GmbH

9.1.5.1 Business overview

9.1.5.2 Product and service offerings

9.1.6 Perrigo Company plc

9.1.6.1 Business overview

9.1.6.2 Product and service offerings

9.1.7 Eli Lilly & Company

9.1.7.1 Business overview

9.1.7.2 Product and service offerings

9.1.8 Sanofi

9.1.8.1 Business overview

9.1.8.2 Product and service offerings

9.1.9 Bayer AG

9.1.9.1 Business overview

9.1.9.2 Product and service offerings

9.2 Strategic Developments in the Animal Pharmaceuticals market

9.2.1 Mergers & acquisitions

9.2.2 Geographical expansion

9.2.3 Product launch

9.2.4 Others

Chapter 10. Appendix

10.1 List of Abbreviations

 

LIST OF TABLES 

TABLE 1: ANALYSIS YEARS CONSIDERED FOR THIS PUBLICATION

TABLE 2: SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 3: GLOBAL ANIMAL PHARMACEUTICALS MARKET SNAPSHOT

TABLE 4: DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5: RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 7: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 8: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2012 – 2015)

TABLE 9: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2016 – 2022)

TABLE 10: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY REGION, $M (2012 – 2015)

TABLE 11: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY REGION, $M (2016 – 2022)

TABLE 12: GLOBAL ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 13: GLOBAL ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 14: GLOBAL ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 15: GLOBAL ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 16: GLOBAL ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 17: GLOBAL ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 18: GLOBAL ANIMAL BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 19: GLOBAL ANIMAL BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 20: GLOBAL COMPANION ANIMAL PHARMACEUTICALS  MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 21: GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 22: GLOBAL CANINE PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 23: GLOBAL CANINE PHARMACEUTICALS  MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 24: GLOBAL CANINE ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 25: GLOBAL CANINE ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 26: GLOBAL CANINE ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 27: GLOBAL CANINE ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 28: GLOBAL CANINE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 29: GLOBAL CANINE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 30: GLOBAL CANINE BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 31: GLOBAL CANINE BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 32: GLOBAL FELINE PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 33: GLOBAL FELINE ECTOPARASITICIDES  MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 34: GLOBAL FELINE ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 35: GLOBAL FELINE ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 36: GLOBAL FELINE ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 37: GLOBAL FELINE ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 38: GLOBAL FELINE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 39: GLOBAL FELINE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 40: GLOBAL FELINE BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 41: GLOBAL FELINE BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 42: GLOBAL EQUINE PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 43: GLOBAL EQUINE PHARMACEUTICALS  MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 44: GLOBAL EQUINE ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 45: GLOBAL EQUINE ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 46: GLOBAL EQUINE ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 47: GLOBAL EQUINE ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 48: GLOBAL EQUINE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 49: GLOBAL EQUINE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 50: GLOBAL EQUINE BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 51: GLOBAL EQUINE BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 52: GLOBAL PRODUCTION ANIMAL PHARMACEUTICALS  MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 53: GLOBAL PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 54: GLOBAL LIVESTOCK PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 55: GLOBAL LIVESTOCK PHARMACEUTICALS  MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 56: GLOBAL LIVESTOCK ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 57: GLOBAL LIVESTOCK ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 58: GLOBAL LIVESTOCK ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 59: GLOBAL LIVESTOCK ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 60: GLOBAL LIVESTOCK ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 61: GLOBAL LIVESTOCK ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 62: GLOBAL POULTRY ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 63: GLOBAL POULTRY ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 64: GLOBAL POULTRY ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 65: GLOBAL POULTRY ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 66: NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 67: NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 68: NORTH AMERICA ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 69: NORTH AMERICA ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 70: NORTH AMERICA ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 71: NORTH AMERICA ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 72: NORTH AMERICA ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 73: NORTH AMERICA ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 74: NORTH AMERICA BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 75: NORTH AMERICA BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 76: NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2012 – 2015)

TABLE 77: NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2016 – 2022)

TABLE 78: NORTH AMERICA COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 79: NORTH AMERICA COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 80: NORTH AMERICA PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 81: NORTH AMERICA PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 82: NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 83: NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 84: U.S. ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 85: U.S. ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 86: EUROPE ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 87: EUROPE ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 88: EUROPE ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 89: EUROPE ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 90: EUROPE ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 91: EUROPE ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 92: EUROPE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 93: EUROPE ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 94: EUROPE BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 95: EUROPE BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 96: EUROPE ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2012 – 2015)

TABLE 97: EUROPE ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2016 – 2022)

TABLE 98: EUROPE COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 99: EUROPE COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 100: EUROPE PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 101: EUROPE PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 102: EUROPE ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 103: EUROPE ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 104: GERMANY ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 105: GERMANY ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 106: FRANCE ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 107: FRANCE ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 108: U.K. ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 109: U.K. ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 110: ITALY ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 111: ITALY ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 112: ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 113: ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 114: ASIA-PACIFIC ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 115: ASIA-PACIFIC ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 116: ASIA-PACIFIC ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 117: ASIA-PACIFIC ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 118: ASIA-PACIFIC ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 119: ASIA-PACIFIC ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 120: ASIA-PACIFIC BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 121: ASIA-PACIFIC BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 122: ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2012 – 2015)

TABLE 123: ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2016 – 2022)

TABLE 124: ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 125: ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 126: ASIA-PACIFIC PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 127: ASIA-PACIFIC PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 128: ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 129: ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 130: CHINA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 131: CHINA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 132: INDIA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 133: INDIA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 134: AUSTRALIA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 135: AUSTRALIA ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 136: ROW ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 137: ROW ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 138: ROW ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 139: ROW ECTOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 140: ROW ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 141: ROW ENDOPARASITICIDES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 142: ROW ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2015)

TABLE 143: ROW ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2016 – 2022)

TABLE 144: ROW BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2015)

TABLE 145: ROW BRONCHODILATORS MARKET, BY TYPE, $M (2016 – 2022)

TABLE 146: ROW ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2012 – 2015)

TABLE 147: ROW ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2016 – 2022)

TABLE 148: ROW COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 149: ROW COMPANION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 150: ROW PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2012 – 2015)

TABLE 151: ROW PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY SPECIE, $M (2016 – 2022)

TABLE 152: ROW ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2012 – 2015)

TABLE 153: ROW ANIMAL PHARMACEUTICALS MARKET, BY COUNTRY, $M (2016 – 2022)

TABLE 154: BRAZIL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2015)

TABLE 155: BRAZIL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2016 – 2022)

TABLE 156: MERCK & CO., INC. – KEY FACTS

TABLE 157: VETOQUINOL S.A. – KEY FACTS

TABLE 158: ZOETIS INC – KEY FACTS

TABLE 159: VIRBAC SA – KEY FACTS

TABLE 160: BOEHRINGER INGELHEIM GMBH – KEY FACTS

TABLE 161: PERRIGO COMPANY PLC – KEY FACTS

TABLE 162: ELI LILLY & COMPANY – KEY FACTS

TABLE 163: SANOFI – KEY FACTS

TABLE 164: BAYER AG – KEY FACTS

 

LIST OF FIGURES 

FIG 1: RESEARCH SCOPE FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET

FIG 2: RESEARCH METHODOLOGY FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET

FIG 3: KEY FINDINGS FOR GLOBAL ANIMAL PHARMACEUTICALS MARKET

FIG 4: GDP (PPP) PER CAPITA INCOME OF SOME EMERGING ECONOMIES (2000 – 2015)

FIG 5: GLOBAL MEAT PRODUCTION, MILLION TONS (2013 – 2015)

FIG 6: GLOBAL MILK PRODUCTION, MILLION TONS (2013 – 2015)

FIG 7: GLOBAL ANIMAL HEALTHCARE MARKET, BY PRODUCT

FIG 8: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2022)

FIG 9: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE, $M (2012 – 2022)

FIG 10: GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY REGION, $M (2012 – 2022)

FIG 11: GLOBAL ANIMAL PHARMACEUTIALS MARKET SHARE (2015)

FIG 12: GLOBAL ECTOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2022)

FIG 13: GLOBAL ENDOPARASITICIDES MARKET, BY TYPE, $M (2012 – 2022)

FIG 14: GLOBAL ANTI-INFLAMMATORIES MARKET, BY TYPE, $M (2012 – 2022)

FIG 15: GLOBAL ANIMAL BRONCHODILATORS MARKET, BY TYPE, $M (2012 – 2022)

FIG 16: GLOBAL ANIMAL PHARMACEUTIALS MARKET SHARE (2015)

FIG 17: GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2022)

FIG 18: GLOBAL PRODUCTION ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT, $M (2012 – 2022)

FIG 19: GLOBAL ANIMAL PHARMACEUTIALS MARKET, BY REGION

FIG 20: PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 21: COMPETITIVE POSITIONING OF GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT

The research offers actual historical market size for the period 2012-2015 and market forecast for the period 2016-2022 in terms of U.S. dollars.
GLOBAL ANIMAL PHARMACEUTICALS MARKET

  • By Product
  • By Animal Type
  • By Region

GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY PRODUCT

  • Ectoparasiticides
    • Ivermectin
    • Cypermethrin
    • Fipronil
    • Coumaphos
    • Others
  • Endoparasiticides
    • Ivermectin
    • Praziquantel
    • Flubendazole
    • Milbemycin
    • Levamisole
    • Fenbendazole
    • Pyrantel
    • Others
  • Anti-Inflammatories
    • NSAIDs
    • Corticosteroids
    • Others
  • Bronchodilators
    • Theophylline
    • Albuterol
    • Others
  • Others

GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY ANIMAL TYPE

  • Companion Animals
    • Canine
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Firponil, and others
        • Endoparasiticides – Includes Praziquantel, Ivermectin, Milbemycin, Pyrantel, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Bronchodilators – Includes Theophylline, Albuterol, and Others
        • Others
    • Feline
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Firponil, and others
        • Endoparasiticides – Includes Praziquantel, Ivermectin, Milbemycin, Pyrantel, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Bronchodilators – Includes Theophylline, Albuterol, and Others
        • Others
    • Equine
      • By Product
        • Ectoparasiticides – Includes Cypermethrin, and others
        • Endoparasiticides – Includes Praziquantel, Ivermectin, Milbemycin, Pyrantel, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Bronchodilators – Includes Theophylline, Albuterol, and Others
        • Others
  • Production Animals
    • Livestock
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Cypermethrin, Coumaphos, and others
        • Endoparasiticides – Includes Ivermectin, Livamisole, Fenbendazole, and Others
        • Anti-inflammatories -  Includes Corticosteroids, NSAIDs, and Others
        • Others
    • Poultry
      • By Product
        • Ectoparasiticides – Includes Ivermectin, Cypermethrin, Coumaphos, and Others
        • Endoparasiticides – Includes Flubendazole, and Others
        • Others

GLOBAL ANIMAL PHARMACEUTICALS MARKET, BY GEOGRAPHY

North America Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – U.S., and Rest of North America
    • U.S. Animal Pharmaceuticals Market
      • By Product

Europe Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – Germany., France, U.K., Italy and Rest of Europe
    • Germany Animal Pharmaceuticals Market
      • By Product
    • France Animal Pharmaceuticals Market
      • By Product
    • U.K. Animal Pharmaceuticals Market
      • By Product
    • Italy Animal Pharmaceuticals Market
      • By Product

Asia-Pacific Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – China, India, Australia and Rest of Asia-Pacific
    • China Animal Pharmaceuticals Market
      • By Product
    • India Animal Pharmaceuticals Market
      • By Product
    • Australia Animal Pharmaceuticals Market
      • By Product

Rest of the World (RoW) Animal Pharmaceuticals Market

  • By Product
  • By Animal Type
  • By Country – Brazil, and Rest of RoW
    • Brazil Animal Pharmaceuticals Market
  • By Product

Please fill the form to get the sample pages.

  

Place An Order

Single User License

Single User License authorizes access of the publication to single user, i.e. the buyer of the report.

$5500
Group License

Group License authorizes access of the publication upto 5 users.

$6500
Site License

Site License authorizes access of the publication to all the employees of the organization at a single geographic location.

$8100
Enterprise License

Enterprise License provides right to distribute copies of the publication across the organization and its subsidiaries.

$11100
down-arrow

Pre-Purchase Enquiry